Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Biliary Tract Neoplasms × cediranib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Fallopian Tube Neoplasms 6 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Neoplasms 4 Glioblastoma 4 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Sarcoma, Alveolar Soft Part 2 Sarcoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Gliosarcoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uveal Melanoma 1 Thyroid cancer, Hurthle cell 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Gemcitabine 14 Cisplatin 10 Nivolumab 6 pembrolizumab 4 Oxaliplatin 4 Capecitabine 4 trametinib 3 tremelimumab 2 lenvatinib 2 durvalumab 2 derazantinib 2 atezolizumab 2 Ramucirumab 2 Radiofrequency Ablation 2 Fluorouracil 2 Cryosurgery 2 Bevacizumab 2 zanidatamab 1 vandetanib 1 tocilizumab 1 telotristat ethyl 1 sargramostim 1 rucaparib 1 regorafenib 1 pertuzumab 1 merestinib 1 irinotecan sucrosofate 1 devimistat 1 dabrafenib 1 cytokine inducible SH2-containing protein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡